This inventor holds 6 USPTO granted patents and 5 published patent applications and 1 EPO patent. Top assignees: Centre National De La Recherche Scientifique, Institut Curie, National Institute of Health and Medical Research. Active years: 2018-2026.
Company Filing History:
5 out of 5,383 
5 out of 162 
5 out of 1,853 
Years Active: 2018-2026
Title: Sandrine Moutel: Innovator in Synthetic Antibody Technology
Introduction
Sandrine Moutel is a prominent inventor based in Paris, France. She has made significant contributions to the field of biotechnology, particularly in the development of synthetic single domain antibodies. With a total of five patents to her name, her work has the potential to revolutionize therapeutic applications.
Latest Patents
Among her latest patents is the invention related to a highly stable single domain antibody scaffold known as hs2dAb. This invention focuses on generating a synthetic single domain antibody library, referred to as hs2dAb-L1. The patent also encompasses antigen-binding proteins that utilize this stable scaffold, highlighting their potential use as therapeutics.
Career Highlights
Sandrine has worked with esteemed institutions such as the Institut National de la Santé et de la Recherche Médicale and Institut Curie. Her experience in these organizations has allowed her to advance her research and contribute to significant scientific advancements.
Collaborations
Throughout her career, Sandrine has collaborated with notable colleagues, including Franck Perez and Aurelien Olichon. These partnerships have further enriched her research and innovation in the field.
Conclusion
Sandrine Moutel stands out as a leading inventor in the realm of synthetic antibodies. Her innovative work and collaborations continue to pave the way for advancements in therapeutic applications.